These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1089961)

  • 1. [Advances in endocrinology. Somatostatin. New hypothalamic hormone inhibiting the secretion of the growth hormone].
    Sliwowski A
    Pol Arch Med Wewn; 1975 Mar; 53(3):287-91. PubMed ID: 1089961
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatostatin: hypothalamic inhibitor of the endocrine pancreas.
    Koerker DJ; Ruch W; Chideckel E; Palmer J; Goodner CJ; Ensinck J; Gale CC
    Science; 1974 Apr; 184(4135):482-4. PubMed ID: 4594711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Growth-hormone release-inhibiting hormone.
    Lancet; 1974 Jun; 1(7867):1148-50. PubMed ID: 4136663
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatostatin, basic and clinical studies. A review.
    Schally AV; Meyers CA
    Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone neuroregulation and the clinical relevance of somatostatin.
    Wass JA
    Clin Endocrinol Metab; 1983 Nov; 12(3):695-724. PubMed ID: 6142779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secretion of growth hormone and insulin in patients with acromegaly].
    Ulrich E; Seige K; Schneyer U; Wilhelmsen E; Hädecke J
    Z Gesamte Inn Med; 1973 Mar; 28(5):141-2 passim. PubMed ID: 4350299
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Somatostatin action on pancreas.
    Koerker DJ; Goodner CJ; Ruch W
    N Engl J Med; 1974 Aug; 291(5):262-3. PubMed ID: 4209407
    [No Abstract]   [Full Text] [Related]  

  • 8. Disappearance of plasma growth hormone in acromegaly and protein-calorie malnutrition after somatostatin.
    Pimstone BL; Becker D; Kronheim S
    J Clin Endocrinol Metab; 1975 Jan; 40(1):168-71. PubMed ID: 803512
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Effect of growth hormone release inhibiting hormone on the release of growth hormone and other pituitary hormones in man.
    Schally AV; Coy DM; Kastin AJ; Tunbridge WM; Evered DC; Weightman D; Hall R; Besser GM; Goldie DJ; McNeilly AS; Mortimer CH; Phenekos C
    J Endocrinol; 1974 Apr; 61(1):XIV. PubMed ID: 4208301
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of aminophylline on the secretion of insulin, glucagon, luteinizing hormone and growth hormone in humans.
    Ensinck JW; Stoll RW; Gale CC; Santen RJ; Touber JL; Williams RH
    J Clin Endocrinol Metab; 1970 Aug; 31(2):153-61. PubMed ID: 4316527
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of synthetic somatostatin in normal and acromegalic males].
    Wiegelmann W; Solbach HG; Kley HK; Rudorff KH; Herrmann J; Zimmermann H; Krüskemper HL
    Dtsch Med Wochenschr; 1975 Feb; 100(8):331-4. PubMed ID: 1090428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of somatostatin action on insulin release in man. I. Effect of blockade of alpha-adrenergic receptors.
    Efendić S; Luft R
    Acta Endocrinol (Copenh); 1975 Mar; 78(3):516-23. PubMed ID: 1091119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
    Yen SS; Siler TM; DeVane GW
    N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
    Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
    Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CNS control of glucose metabolism.
    Grote EH
    Acta Neurochir Suppl (Wien); 1981; 31():1-160. PubMed ID: 6114617
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues.
    Coy DH; Meyers C; Arimura A; Schally AV; Redding TW
    Metabolism; 1978 Sep; 27(9 Suppl 1):1407-10. PubMed ID: 683009
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats.
    Grant N; Clark D; Garsky V; Jaunakais I; McGregor W; Sarantakis D
    Life Sci; 1976 Sep; 19(5):629-31. PubMed ID: 957897
    [No Abstract]   [Full Text] [Related]  

  • 19. [Somatostatin -- a review (author's transl)].
    Lucke C; Mitzkat HJ; von zur Mühlen A
    Klin Wochenschr; 1976 Apr; 54(7):293-301. PubMed ID: 1263405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of immunoreactive insulin and human growth hormone release by administration of arginine in patients with diabetic retinopathy.
    Waldhäusl W
    Acta Endocrinol (Copenh); 1972 Aug; 70(4):719-30. PubMed ID: 5068400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.